Evaluation of Efficacy and Safety of HMR1964 (Insulin Glulisine) in Subjects With Type 1 Diabetes Mellitus; Insulin Lispro Controlled, Open, Randomized, Parallel Group, Non-Inferiority Study, for 28 Weeks.
Phase of Trial: Phase III
Latest Information Update: 01 Oct 2009
At a glance
- Drugs Insulin glulisine; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 01 Oct 2009 Results published in Diabetes, Obesity and Metabolism,
- 01 Oct 2009 Primary endpoint 'Proportion of glycosylated haemoglobin' has been met according to results published in Diabetes, Obesity and Metabolism.
- 13 Sep 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History